Protein engineering strategies to optimize activity of surface attached proteins

• US 20100260465A1
• Filed: 12/21/2006
• Published: 10/14/2010
• Est. Priority Date: 12/22/2005
• Status: Abandoned Application

• Current Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Original Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Inventors: Otto, Geoff, Rank, David, Hanzel, David, Pham, Thang, Peluso, Paul, Turner, Stephen, Korlach, Jonas
• Application Number:
  US11/645,135
• Publication Number:
  US 20100260465A1
• Time in Patent Office: Days
• US Class Current: 385/141
• CPC Class Codes: C07K 2319/21 containing a His-tag
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113
• CPC Class Codes: Y10T 428/2991 Coated
• CPC Class Codes: Y10T 428/2993 Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
• CPC Class Codes: Y10T 428/2996 Glass particles or spheres
• CPC Class Codes: Y10T 428/31663 As siloxane, silicone or silane
• CPC Class Codes: Y10T 428/31768 Natural source-type polyamide [e.g., casein, gelatin, etc.]

Abstract

Isolated and/or recombinant enzymes that include surface binding domains, surfaces with active enzymes bound to them and methods of coupling enzymes to surfaces are provided. Enzymes can include large and/or multiple surface coupling domains for surface coupling.

Claims

1. An isolated or recombinant enzyme comprising a plurality of artificial or recombinant surface coupling domains, wherein the enzyme, when coupled to a surface through the surface coupling domains, is enzymatically active.

2. The isolated or recombinant enzyme of claim 1, wherein the enzyme is selected from:

a polymerase, a DNA polymerase, an RNA polymerase, a reverse transcriptase, a helicase, a kinase, a caspase, a phosphatase, a terminal transferase, an endonuclease, an exonuclease, a dehydrogenase, a peptidase, a beta-lactamase, a beta-galactosidase, and a luciferase.

3. The isolated or recombinant enzyme of claim 2, wherein the enzyme is a polymerase homologous to:

a Taq polymerase, an exonuclease deficient Taq polymerase, an E. coli DNA Polymerase 1, a Klenow fragment, a reverse transcriptase, a Φ

29 related polymerase, a wild type Φ

29 polymerase, an exonuclease deficient Φ

29 polymerase, a T7 DNA Polymerase, a T5 DNA Polymerase;

or

wherein the enzyme is a polymerase homologous to a Φ

29 DNA polymerase, and comprises a structural modification relative to the Φ

29 DNA polymerase selected from;

a deletion of residues 505-525, a deletion within residues 505-525, a K135A mutation, an E375H mutation, an E375S mutation, an E375K mutation, an E375R mutation, an E375A mutation, an E375Q mutation, an E375W mutation, an E375Y mutation, an E375F mutation, an L384R mutation, an E486A mutation, an E486D mutation, a K512A mutation, an N62D mutation, a D12A mutation, and combinations thereof.

4. The isolated or recombinant enzyme of claim 1, wherein at least one of the artificial surface coupling domains comprise:

a recombinant dimer domain of the enzyme, a large extraneous polypeptide domain, a polyhistidine tag, a HIS-6 tag, a biotin, an avidin sequence, a GST sequence, a glutathione, a AviTag sequence, an S tag, an antibody, an antibody domain, an antibody fragment, an antigen, a receptor, a receptor domain, a receptor fragment, a ligand, a dye, an acceptor, a quencher, or a combination thereof.

5. The isolated or recombinant enzyme of claim 1, comprising at least two different artificial coupling domains that are specifically bound by at least two different cognate binding components.

6. The isolated or recombinant enzyme of claim 1, comprising at least three different artificial coupling domains that are specifically bound by at least three different cognate binding components.

7. The isolated or recombinant enzyme of claim 1, wherein the enzyme comprises 3 or more artificial or recombinant surface coupling domains.

8. The isolated or recombinant enzyme of claim 1, wherein the enzyme comprises 5 or more artificial or recombinant surface coupling domains.

9. The isolated or recombinant enzyme of claim 1, wherein the enzyme comprises 10 or more artificial or recombinant surface coupling domains.

10. The isolated or recombinant enzyme of claim 1, wherein at least one of the artificial surface coupling domains comprises a purification tag.

11. The isolated or recombinant enzyme of claim 1, wherein the artificial surface coupling domains are distal to an active site of the enzyme.

12. The isolated or recombinant enzyme of claim 1, wherein the active site is located within a C-terminal domain of the enzyme, and the artificial surface coupling domain is located within an N-terminal domain of the enzyme.

13. The isolated or recombinant enzyme of claim 1, wherein binding of the enzyme to a surface through the surface coupling domains orients the enzyme relative to the surface.

14. The isolated or recombinant enzyme of claim 1, wherein binding of the enzyme to a surface through at least two of the surface coupling domains has a higher binding affinity than binding of the enzyme to the surface through a single surface coupling domain.

15. The isolated or recombinant enzyme of claim 1, wherein the enzyme, when bound to the surface, retains a k_cat/K_m that is at least 1% as high as the enzyme in solution.

16. The isolated or recombinant enzyme of claim 1, wherein the enzyme, when bound to the surface, retains a k_cat/K_m that is at least 10% as high as the enzyme in solution.

17. The isolated or recombinant enzyme of claim 1, wherein the enzyme, when bound to the surface, retains a k_cat/K_m that is at least 50% as high as the enzyme in solution.

18. The isolated or recombinant enzyme of claim 1, wherein the enzyme, when bound to the surface, retains a k_cat/K_m that is at least 75% as high as the enzyme in solution.

19. A surface comprising an active enzyme bound thereon, wherein the enzyme is coupled to the surface through a plurality of artificial or recombinant surface coupling domains, and wherein the active enzyme displays a k_cat/K_m that is at least 10% as high as a corresponding active enzyme in solution.

20. The surface of claim 19, wherein a location of the enzyme on the surface is fixed, thereby providing a spatial address of the enzyme on the surface.

21. The surface of claim 19, wherein the surface is a planar surface.

22. The surface of claim 19, wherein the surface comprises a polymer, a ceramic, glass, a bead, a microbead, a polymer bead, a glass bead, a well, a microwell, a slide, a grid, a rotor, a microchannel, or a combination thereof.

24. The surface of claim 19, wherein the surface comprises one or more immobilized components selected from:

a dye, an acceptor, a quencher, an immobilized metal, an immobilized glutathione, an immobilized antibody, an immobilized antibody fragment, an immobilized antigen, an immobilized receptor, an immobilized receptor fragment, an immobilized ligand, an immobilized hapten, an immobilized biotin, an immobilized avidin, an immobilized GST sequence, glutathione, an immobilized AviTag sequence, an immobilized S tag, an immobilized S protein, and a combination thereof; and

wherein the surface coupling domains specifically bind to the immobilized components.

25. The surface of claim 19, wherein the surface coupling domains comprise at least two different domains and wherein the immobilized component comprises at least two different immobilized components.

26. The surface of claim 25, wherein the at least two different domains are concurrently bound to the at least two different immobilized components.

27. The surface of claim 19, wherein the surface coupling domains are distal to an active site of the enzyme.

28. The surface of claim 19, wherein the k_cat/K_m that is at least 50% as high as a corresponding active enzyme in solution.

29. The surface of claim 19, wherein the K_cat/K_m that is at least 75% as high as a corresponding active enzyme in solution.

30. The surface of claim 19, wherein the active site is located within a C-terminal domain of the enzyme, and the artificial surface coupling domain is located within an N-terminal domain of the enzyme.

31. The surface of claim 19, wherein binding of the enzyme to the surface through the surface coupling domains orients the enzyme relative to the surface.

32. The surface of claim 19, wherein binding of the enzyme to the surface through at least two of the surface coupling domains has a higher binding affinity than binding of the enzyme to the surface through a single surface coupling domain.

33. The surface of claim 19, wherein the enzyme is selected from:

a polymerase, a DNA polymerase, an RNA polymerase, a reverse transcriptase, a helicase, a kinase, a caspase, a phosphatase, a terminal transferase, an endonuclease, an exonuclease, a dehydrogenase, a peptidase, a beta-lactamase, a beta-galactosidase, and a luciferase;

or

wherein the enzyme is a polymerase homologous to;

a Taq polymerase, an exonuclease deficient Taq polymerase, an E. coli DNA Polymerase 1, a Klenow fragment, a reverse transcriptase, a Φ

29 related polymerase, a wild type Φ

29 polymerase, an exonuclease deficient Φ

29 polymerase, a T7 DNA Polymerase, a T5 DNA Polymerase;

or

wherein the enzyme is a polymerase homologous to a Φ

29 DNA polymerase, and comprises a structural modification relative to the Φ

29 DNA polymerase selected from;

a deletion of residues 505-525, a deletion within residues 505-525, a K135A mutation, an E375H mutation, an E375S mutation, an E375K mutation, an E375R mutation, an E375A mutation, an E375Q mutation, an E375W mutation, an E375Y mutation, an E375F mutation, an L384R mutation, an E486A mutation, an E486D mutation, a K512A mutation, an N62D mutation, a D12A mutation, and combinations thereof.

34. A method of binding an enzyme to a surface, the method comprising:

providing an isolated or recombinant enzyme comprising a plurality of artificial or recombinant surface coupling domains;

providing a surface comprising a plurality of binding partners that specifically bind to the surface coupling domains;

contacting the enzyme to the surface; and

,

permitting the binding partners to bind to the surface coupling domains, thereby binding the enzyme to the surface.

35. The method of claim 34, further comprising releasing the enzyme from the surface subsequent to binding the enzyme to the surface.

36. The method of claim 34, wherein the surface coupling domain is activateable.

37. The method of claim 34, wherein the surface coupling domain is caged and the method includes uncaging the surface coupling domain, thereby permitting the binding partners to bind to the surface coupling domains.

38. The method of claim 34, wherein the surface coupling domain is photocaged and the method includes uncaging the surface coupling domain, thereby permitting the binding partners to bind to the surface coupling domains.

39. An isolated or recombinant active site-containing protein comprising:

an artificial or recombinant surface coupling domain that is at least 5 kDa in size, wherein the protein, when coupled to a surface through the surface coupling domain, retains at least 1% activity as compared to an activity of a corresponding active protein in solution.

40. The isolated of recombinant protein of claim 39, wherein the protein retains at least 10% activity.

41. The isolated of recombinant protein of claim 39, wherein the surface coupling domain is at least 10 kDa.

42. The isolated or recombinant protein of claim 39, wherein the surface coupling domain is at least 20 kDa.

43. The isolated or recombinant protein of claim 39, wherein the surface coupling domain is at least 50 kDa.

44. The isolated or recombinant protein of claim 39, wherein the surface coupling domain is at least 100 kDa.

45. The isolated or recombinant protein of claim 39, wherein the surface coupling domain is at least 1000 kDa.

46. The isolated or recombinant protein of claim 39, wherein the surface coupling domain comprises one or more of:

a recombinant dimer domain of the protein, a large extraneous polypeptide domain, a polyhistidine tag, a HIS-6 tag, a biotin, an avidin sequence, a GST sequence, a glutathione, a AviTag sequence, an S tag, an antibody, an antibody domain, an antibody fragment, an antigen, a receptor, a receptor fragment, a ligand, a dye, an acceptor, a quencher, or a combination thereof.

47. The isolated or recombinant protein of claim 39, wherein the protein comprises at least two surface coupling domains.

48. The isolated or recombinant protein of claim 39, wherein the protein comprises three or more surface coupling domains.

49. The isolated or recombinant protein of claim 39, wherein binding of the protein to the surface through the surface coupling domain specifically orients the protein relative to the surface.

50. The isolated or recombinant protein of claim 39, wherein the protein is selected from:

an enzyme, a receptor, an antibody, a polymerase, a DNA polymerase, an RNA polymerase, a reverse transcriptase, a helicase, a kinase, a caspase, a phosphatase, a terminal transferase, an endonuclease, an exonuclease, a dehydrogenase, a peptidase, a beta-lactamase, a beta-galactosidase, and a luciferase.

51. The isolated or recombinant protein of claim 39, wherein the protein is a polymerase homologous to:

a Phi29 DNA polymerase, a Taq polymerase, an exonuclease deficient Taq polymerase, an E. coli DNA Polymerase 1, a Klenow fragment, a reverse transcriptase, a Φ

29 related polymerase, a wild type Φ

29 polymerase, an exonuclease deficient Φ

29 polymerase, a T7 DNA Polymerase, a T5 DNA Polymerase;

or

wherein the enzyme is a polymerase homologous to a Φ

29 DNA polymerase, and comprises a structural modification relative to the Φ

29 DNA polymerase selected from;

a deletion of residues 505-525, a deletion within residues 505-525, a K135A mutation, an E375H mutation, an E375S mutation, an E375K mutation, an E375R mutation, an E375A mutation, an E375Q mutation, an E375W mutation, an E375Y mutation, an E375F mutation, an L384R mutation, an E486A mutation, an E486D mutation, a K512A mutation, an N62D mutation, a D12A mutation, and combinations thereof.

52. The isolated or recombinant protein of claim 39, wherein the protein retains at least 50% activity when coupled to the surface.

53. The isolated or recombinant protein of claim 39, wherein the protein retains at least 75% activity when coupled to the surface.

54. A surface comprising a protein bound thereon, wherein the protein is coupled to the surface through an artificial or recombinant surface coupling domain that is at least 5 kDa in size, wherein the protein displays an activity that is at least 10% as high as a corresponding active protein in solution.

23. The surface of claim 54, wherein the surface comprises or is proximal to a Zero Mode Wave Guide.

55. The surface of claim 54, wherein a location of the enzyme on the surface is fixed, thereby providing a spatial address of the enzyme on the surface.

56. The surface of claim 54, wherein the surface is a planar surface.

57. The surface of claim 54, wherein the surface comprises a polymer, a ceramic, glass, a bead, a microbead, a polymer bead, a glass bead, a well, a microwell, a slide, a grid, a rotor, a microchannel, or a combination thereof.

58. The surface of claim 54, wherein the surface comprises or is proximal to a Zero Mode Wave Guide.

59. The surface of claim 54, wherein the surface comprises one or more immobilized component selected from:

a dye, an acceptor, a quencher, an immobilized metal, an immobilized glutathione, an immobilized antibody, an immobilized antibody fragment, an immobilized antigen, a an immobilized receptor, a an immobilized receptor fragment, an immobilized ligand, an immobilized hapten, an immobilized biotin, an immobilized avidin, an immobilized GST sequence, a glutathione, an immobilized AviTag sequence, an immobilized S tag, and a combination thereof; and

wherein the surface coupling domain specifically binds to the immobilized component.

60. The surface of claim 59, wherein the protein comprises at least two different surface coupling domains and wherein the surface comprises at least two different immobilized components, each of which specifically bind to at least one of the two different surface coupling domains.

61. The surface of claim 60, wherein the at least two different domains are concurrently bound to the at least two different immobilized components.

62. The surface of claim 54, wherein the surface coupling domain is distal to the active site.

63. The surface of claim 54, wherein activity is at least 50% as high as a corresponding active protein in solution.

64. The surface of claim 54, wherein the activity is at least 75% as high as a corresponding active protein in solution.

65. The surface of claim 54, wherein the active site is located within a C-terminal domain of the protein, and the artificial surface coupling domain is located within an N-terminal domain of the protein.

66. The surface of claim 54, wherein binding of the protein to the surface through the surface coupling domain orients the protein relative to the surface.

67. The surface of claim 54, wherein the protein is selected from:

an enzyme, an antibody, a receptor, a polymerase, a DNA polymerase, an RNA polymerase, a reverse transcriptase, a helicase, a kinase, a caspase, a phosphatase, a terminal transferase, an endonuclease, an exonuclease, a dehydrogenase, a peptidase, a beta-lactamase, a beta-galactosidase, and a luciferase;

or

wherein the protein is a polymerase homologous to;

a Taq polymerase, an exonuclease deficient Taq polymerase, an E. coli DNA Polymerase 1, a Klenow fragment, a reverse transcriptase, a Φ

29 related polymerase, a wild type Φ

29 polymerase, an exonuclease deficient Φ

29 polymerase, a T7 DNA Polymerase, a T5 DNA Polymerase;

or

wherein the protein is a polymerase homologous to a Φ

29 DNA polymerase, and comprises a structural modification relative to the Φ

29 DNA polymerase selected from;

a deletion of residues 505-525, a deletion within residues 505-525, a K135A mutation, an E375H mutation, an E375S mutation, an E375K mutation, an E375R mutation, an E375A mutation, an E375Q mutation, an E375W mutation, an E375Y mutation, an E375F mutation, an L384R mutation, an E486A mutation, an E486D mutation, a K512A mutation, an N62D mutation, a D12A mutation, and combinations thereof.

68. A method of binding a protein to a surface, the method comprising:

providing an isolated or recombinant protein comprising an artificial or recombinant surface coupling domain that is at least 5 kDa in size;

providing a surface comprising a binding partner that specifically binds to the surface coupling domain;

contacting the protein to the surface; and

,

permitting the binding partner to bind to the surface coupling domain, thereby binding the enzyme to the surface;

wherein the protein, when bound to the surface is at least 10% as active as the protein in solution.

69. The method of claim 68, comprising releasing the protein from the surface subsequent to binding the protein to the surface.

70. The method of claim 68, wherein the surface coupling domain is activateable.

71. The method of claim 68, wherein the surface coupling domain is caged and the method includes uncaging the surface coupling domain, thereby permitting the binding partners to bind to the surface coupling domains.

72. The method of claim 68, wherein the surface coupling domain is photocaged and the method includes uncaging the surface coupling domain, thereby permitting the binding partners to bind to the surface coupling domains.